Idiopathic Generalized Epilepsy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for idiopathic generalized epilepsy. 16 active patents protecting 2 drugs from 2+ originators. First major cliff: 2040. Daily refresh.

2
Approved drugs
16
Active US patents
50/100
Avg vulnerability
$300M
Annual revenue covered

Originators in Idiopathic Generalized Epilepsy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

UCB 9 patents Catalyst Pharms 7 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating idiopathic generalized epilepsy. Each bar = one year. Y-axis scaled to peak year (9 patents).

7
26
9
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Vimpat
lacosamide
 UCB 9 73 — 2040-06-05
Fycompa
PERAMPANEL
 Catalyst Pharms 7 26 $300M 2026-07-01

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12042474 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
8772497 Fycompa composition of matter 27 2026-07-01

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8772497 Fycompa composition of matter 22 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
8772497 Fycompa composition of matter 27 2026-07-01
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05

Related